Fig. 6
From: Identification and validation of a refined CAF-Associated diagnostic signature in breast cancer
Two consecutive pathological slides intuitively demonstrate the distinct expression Patterns of FXYD1 and SULF1. (A) The expression of FXYD1 in myoepithelial cells. (B) The expression of FXYD1 in fibroblasts. (C) The expression of SULF1 in fibroblasts. (D) The relationship between SULF1 and different clinicopathological characteristics, including tissue type, age, T stage, N stage, ER status, PR status, and Her2 status.
